Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Senthil Specialty Hospital
WARNING LETTER
•Senthil Specialty Hospital•January 24, 2025

Senthil Specialty Hospital – FDA Warning Letter, Jan 24, 2025

Record Details

The U.S. Food and Drug Administration (FDA) issued a Warning Letter to Purushothaman Damodara Kumaran, M.D., associated with Senthil Specialty Hospital in Pondicherry, Puducherry, India, following an inspection from January 20-24, 2025. The inspection reviewed the conduct of a clinical bioequivalence study for an investigational drug. The FDA found objectionable conditions indicating non-adherence to the Federal Food, Drug, and Cosmetic Act and regulations outlined in 21 CFR Part 312, concerning clinical investigations and human subject protection. The primary violation was Dr. Kumaran's failure to ensure the investigation was conducted according to the investigational plan. Specifically, required weekly safety assessments, including hematology and pulmonary function tests for subjects receiving the investigational drug, were not completed for multiple subjects during crucial periods. The protocol mandated these assessments to monitor for serious adverse events like myelosuppression and pulmonary toxicity. Dr. Kumaran's response, citing pragmatic reasons for modifying the schedule, was deemed inadequate as it lacked evidence of sponsor approval or details on future corrective actions. The FDA emphasized the critical responsibility of clinical investigators to protect subject safety and ensure data integrity. Dr. Kumaran must notify the FDA within 15 business days of actions taken to prevent similar violations in ongoing and future studies.

Company
Senthil Specialty Hospital
Inspection date
January 24, 2025
Product type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Purushothaman Damodara Kumaran
  • Brittany L. Garr-Colón
  • David C. Burrow (Director )
View Company Profile

ID · 7b123e73-5c31-435b-b273-b7859bb723ee

Violation Codes3
21 CFR 312.6021 CFR 31221 CFR 320.31(c)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Senthil Specialty Hospital
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.